Search icon

CANTEX PHARMACEUTICALS, INC. - Florida Company Profile

Company claim

Is this your business?

Get access!

Company Details

Entity Name: CANTEX PHARMACEUTICALS, INC.
Jurisdiction: FLORIDA
Filing Type: Foreign Profit
Status: Active
Date Filed: 02 Oct 2007 (18 years ago)
Last Event: NAME CHANGE AMENDMENT
Event Date Filed: 18 Nov 2013 (12 years ago)
Document Number: F07000004905
FEI/EIN Number 412035780
Address: 1792 BELL TOWER LANE, SUITE 200, WESTON, FL, 33326
Mail Address: 1792 BELL TOWER LANE, SUITE 200, WESTON, FL, 33326
ZIP code: 33326
City: Fort Lauderdale
County: Broward
Place of Formation: DELAWARE

Key Officers & Management

Name Role Address
MARCUS STEPHEN G President 1792 BELL TOWER LANE, WESTON, FL, 33326
MARCUS STEPHEN G Director 1792 BELL TOWER LANE, WESTON, FL, 33326
Flanzraich Neil Director 1792 BELL TOWER LANE, WESTON, FL, 33326
HELLER JORDAN Director 1792 BELL TOWER LANE, WESTON, FL, 33326
RODRIGUEZ JUAN Chief Financial Officer 1792 BELL TOWER LANE, WESTON, FL, 33326
BERTRAND CLAUDE Agent 1792 BELL TOWER LANE, WESTON, FL, 33326

Commercial and government entity program

CAGE number:
60LD4
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2022-07-24
CAGE Expiration:
2026-06-28
SAM Expiration:
2022-07-24

Contact Information

POC:
JUAN RODRIGUEZ

Events

Event Type Filed Date Value Description
NAME CHANGE AMENDMENT 2013-11-18 CANTEX PHARMACEUTICALS, INC. -
CHANGE OF PRINCIPAL ADDRESS 2009-02-17 1792 BELL TOWER LANE, SUITE 200, WESTON, FL 33326 -
CHANGE OF MAILING ADDRESS 2009-02-17 1792 BELL TOWER LANE, SUITE 200, WESTON, FL 33326 -
REGISTERED AGENT ADDRESS CHANGED 2009-02-17 1792 BELL TOWER LANE, SUITE 200, WESTON, FL 33326 -

Documents

Name Date
ANNUAL REPORT 2025-01-15
ANNUAL REPORT 2024-01-15
ANNUAL REPORT 2023-01-24
ANNUAL REPORT 2022-01-24
ANNUAL REPORT 2021-01-11
ANNUAL REPORT 2020-01-15
ANNUAL REPORT 2019-01-21
ANNUAL REPORT 2018-01-30
ANNUAL REPORT 2017-01-30
ANNUAL REPORT 2016-02-08

Trademarks

Serial Number:
88192072
Mark:
ODSH
Status:
Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark
Application Filing Date:
2018-11-13
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
ODSH

Goods And Services

For:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric...
First Use:
2010-10-19
International Classes:
005 - Primary Class
Class Status:
ACTIVE
Serial Number:
87479296
Mark:
DICOPP
Status:
Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark
Application Filing Date:
2017-06-07
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
DICOPP

Goods And Services

For:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric...
First Use:
2018-01-23
International Classes:
005 - Primary Class
Class Status:
SECTION 8 - CANCELLED
Serial Number:
87479273
Mark:
DICOP
Status:
Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark
Application Filing Date:
2017-06-07
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
DICOP

Goods And Services

For:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric...
International Classes:
005 - Primary Class
Class Status:
ACTIVE
Serial Number:
86116194
Mark:
CANTEX PHARMACEUTICALS
Status:
Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Service Mark
Application Filing Date:
2013-11-12
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
CANTEX PHARMACEUTICALS

Goods And Services

For:
research and development of pharmaceutical products and substances
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
98043024
Mark:
CANTEX
Status:
NOTICE OF ALLOWANCE - ISSUED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2023-06-14
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
CANTEX

Goods And Services

For:
Pharmaceuticals, namely, Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses; Pharmaceutical preparations for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases;...
International Classes:
005 - Primary Class
Class Status:
Active
For:
Licensing of pharmaceuticals and drug discovery technologies
International Classes:
045 - Primary Class
Class Status:
Active
For:
Providing medical and scientific research information about the diagnosis and treatment of diseases, namely, infectious diseases, viral diseases, and autoimmune diseases; Providing information in the fields of health, wellness, and pharmaceuticals via a website; all of the foregoing related to Recep...
International Classes:
044 - Primary Class
Class Status:
Active
For:
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Development of new drugs for the prevention and treatment of cancer and other serious illnesses; Design and testing of new drugs and therapies; Medical...
International Classes:
042 - Primary Class
Class Status:
Active

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 02 Aug 2025

Sources: Florida Department of State